153 related articles for article (PubMed ID: 3295553)
1. Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study.
Gharib H; James EM; Charboneau JW; Naessens JM; Offord KP; Gorman CA
N Engl J Med; 1987 Jul; 317(2):70-5. PubMed ID: 3295553
[TBL] [Abstract][Full Text] [Related]
2. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group.
Wémeau JL; Caron P; Schvartz C; Schlienger JL; Orgiazzi J; Cousty C; Vlaeminck-Guillem V
J Clin Endocrinol Metab; 2002 Nov; 87(11):4928-34. PubMed ID: 12414852
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double-blind placebo-controlled clinical trial.
Larijani B; Pajouhi M; Bastanhagh MH; Sadjadi A; Sedighi N; Eshraghian MR
Endocr Pract; 1999; 5(5):251-6. PubMed ID: 15251662
[TBL] [Abstract][Full Text] [Related]
4. Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study.
Cheung PS; Lee JM; Boey JH
World J Surg; 1989; 13(6):818-21; discussion 822. PubMed ID: 2696232
[TBL] [Abstract][Full Text] [Related]
5. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules.
Celani MF; Mariani M; Mariani G
Acta Endocrinol (Copenh); 1990 Dec; 123(6):603-8. PubMed ID: 2284885
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules.
Papini E; Bacci V; Panunzi C; Pacella CM; Fabbrini R; Bizzarri G; Petrucci L; Giammarco V; La Medica P; Masala M
Clin Endocrinol (Oxf); 1993 May; 38(5):507-13. PubMed ID: 8330445
[TBL] [Abstract][Full Text] [Related]
7. Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial.
Koc M; Ersoz HO; Akpinar I; Gogas-Yavuz D; Deyneli O; Akalin S
Clin Endocrinol (Oxf); 2002 Nov; 57(5):621-8. PubMed ID: 12390336
[TBL] [Abstract][Full Text] [Related]
8. [Levothyroxine treatment of the solitary thyroid nodule].
Almodóvar Ruiz F; Maldonado Castro G; de Luis D; Lahera M; Varela da Costa C
An Med Interna; 2000 Feb; 17(2):99-101. PubMed ID: 10829467
[TBL] [Abstract][Full Text] [Related]
9. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
[TBL] [Abstract][Full Text] [Related]
10. The effect of thyroxine-suppressive therapy in patients with solitary non-toxic thyroid nodules -- a randomised, double-blind, placebo-controlled study.
Tsai CC; Pei D; Hung YJ; Wang TF; Tsai WC; Yao CY; Hsieh MC; Kuo SW
Int J Clin Pract; 2006 Jan; 60(1):23-6. PubMed ID: 16409424
[TBL] [Abstract][Full Text] [Related]
11. Suppressive therapy with levothyroxine for solitary thyroid nodules.
Reverter JL; Lucas A; Salinas I; Audí L; Foz M; Sanmartí A
Clin Endocrinol (Oxf); 1992 Jan; 36(1):25-8. PubMed ID: 1559296
[TBL] [Abstract][Full Text] [Related]
12. Changes in both size and cytological features of thyroid nodule after levothyroxine treatment.
Vermiglio F; Lo Presti VP; Violi MA; Moleti M; Castagna MG; Finocchiaro MD; Mattina F; Mandolfino M; Zimbaro G; Trimarchi F
Clin Endocrinol (Oxf); 2003 Sep; 59(3):347-53. PubMed ID: 12919158
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of thyroxine-suppressive therapy and its relation to serum thyroglobulin levels in solitary nontoxic thyroid nodules.
Kuo SW; Hu CA; Pei D; Ni KB; Shian LR
J Formos Med Assoc; 1993 Jan; 92(1):55-60. PubMed ID: 8099828
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].
Diacinti D; Salabè GB; Olivieri A; D'Erasmo E; Tomei E; Lotz-Salabè H; De Martinis C
Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545
[TBL] [Abstract][Full Text] [Related]
15. Short term effects of levothyroxine treatment in thyroid multinodular disease.
Cesareo R; Iozzino M; Isgrò MA; Annunziata F; Di Stasio E
Endocr J; 2010; 57(9):803-9. PubMed ID: 20683172
[TBL] [Abstract][Full Text] [Related]
16. Levothyroxine treatment in pediatric benign thyroid nodules.
Corrias A; Mussa A; Wasniewska M; Segni M; Cassio A; Salerno M; Gastaldi R; Vigone MC; Bal M; Matarazzo P; Weber G; De Luca F
Horm Res Paediatr; 2011; 75(4):246-51. PubMed ID: 21135537
[TBL] [Abstract][Full Text] [Related]
17. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses.
Zelmanovitz F; Genro S; Gross JL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3881-5. PubMed ID: 9814462
[TBL] [Abstract][Full Text] [Related]
18. Levothyroxine suppressive therapy in the medical management of nontoxic benign multinodular goiter.
Celani MF
Exp Clin Endocrinol; 1993; 101(5):326-32. PubMed ID: 8299711
[TBL] [Abstract][Full Text] [Related]
19. [Suppressive hormone therapy for thyroid nodules. Prospective evaluation. Preliminary results].
Wémeau JL; Cousty C; Vlaeminck V
Ann Endocrinol (Paris); 2000 May; 61(2):119-24. PubMed ID: 10891662
[TBL] [Abstract][Full Text] [Related]
20. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid.
La Rosa GL; Lupo L; Giuffrida D; Gullo D; Vigneri R; Belfiore A
Ann Intern Med; 1995 Jan; 122(1):1-8. PubMed ID: 7985890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
